First-in-Human Trial of Oral AN2-502998

NCT07024589 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: AN2-502998
DRUG: Placebo

Sponsor

AN2 Therapeutics, Inc